The largest database of trusted experimental protocols

9 protocols using stat3 sirna

1

miR-125b Expression Analysis in Skin Conditions

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was isolated from HaCaT cells, cholesteatoma, and the corresponding skin with RNAiso plus (TaKaRa Biotechnology Co. Ltd., Dalian, China). The integrity, purity, and concentration of total RNA were analysed by spectrophotometry and gel electrophoresis. Then, the RNA was polyadenylated using E. coli Poly (A) Polymerase (New England Biolabs, MA) and reverse-transcribed into cDNA with a PrimeScriptTM RT reagent Kit with gDNA Eraser (TaKaRa). Finally, quantitative real-time PCR was carried out using a SYBR®Premix Ex Taq™II (TaKaRa) and 7500 real-time PCR system (Applied Biosystems, USA). The relative expression of gene levels was calculated using the 2–ΔΔCT method. U6 served as an internal control normalised the expression data of miR-125b. The sequences of the primers: miR-125b-5p: 5’-TCCCTGAGACCCTAACTTGTGA-3’ miR-reverse: n5’-GCTGTCAACGATACGCTACG-3’; miR-RT primer: 5’-GCTGTCAACGATACGCTACGTAACGGCATGACAGTGTTTTTTTTTTTTTTTTTTTTTTT-3’; U6 forward: 5’-CTCGCTTCGGCAGCACA-3’ and reverse: 5’-AACGCTTCACGAATTTGCGT-3’; HaCaT cells were transiently transfected with miR-125b mimics, miR-125b inhibitor, control miRNA, STAT3 siRNA, and control siRNA (all from RiboBio Co. Ltd., Guangzhou, China), using Lipofectamine® 3000 reagent (Invitrogen, Carlsbad, CA, USA).
+ Open protocol
+ Expand
2

STAT3 Silencing in Cell Culture

Check if the same lab product or an alternative is used in the 5 most similar protocols
STAT3 siRNA (5′-AGUCAGGUUGCUGGUCAAA-3′) and negative control siRNA (siN05815122147) were purchased from Ribobio, Guangzhou, China [28 (link)]. The cells were plated at 50% confluence, transfected with 50 nM siRNA overnight in Opti-MEM containing Lipofectamine 2000 (Invitrogen), and incubated for various amounts of time.
+ Open protocol
+ Expand
3

Transfection of miRNA and siRNA

Check if the same lab product or an alternative is used in the 5 most similar protocols
The miRNA mimic, miRNA inhibitor, STAT3 siRNA, and scrambled siRNA were synthesized by RiBoBio (China). The oligonucleotide sequences were listed in Table S1 (Additional file 1: Table S1). The miRNA overexpression vector pCMV-MIR519A (MI0003182) and the empty vector control were obtained from OriGene (Rockville, MD, USA). The miR-519a sponge and empty vector control were purchased from GeneChem (China). Transfections were performed using Lipofectamine 2000 reagent (cat. no. 11668-019; Invitrogen, Carlsbad, CA, USA) according to the manufacturer’s instructions.
+ Open protocol
+ Expand
4

Transfecting miRNA, siRNA in Neurons

Check if the same lab product or an alternative is used in the 5 most similar protocols
miRNA mimics, miRNA inhibitor, STAT3 siRNA, and their corresponding negative controls (mimics-NC, inhibitor-NC, and si-NC) were synthesized by Ribobio (Guangzhou, China). Transfections in neurons were conducted using either the CP reagent (Ribobio, Guangzhou, China) or Lipofectamine 2000 reagent (Invitrogen, Carlsbad, CA, USA), following the manufacturer’s protocol.
+ Open protocol
+ Expand
5

Gene Silencing and Overexpression Techniques

Check if the same lab product or an alternative is used in the 5 most similar protocols
The PTRH1 siRNA, STAT3 siRNA, and NC siRNA were designed and synthesized by Ribobio (Guangzhou, China). The PTRH1-shRNA and PTRH1-overexpression plasmid were designed and synthesized by ABlife. The siRNA and shRNA sequences are shown in Additional file 14: Table S1. Lipofectamine2000 (Invitrogen, CA, USA) was used for cell transfection followed the manufacturer’s protocol. Nonsilencing (NC)‐shRNA lentivirus (puromycin resistance) and PTRH1‐overexpression lentivirus (puromycin resistance) were purchased from GeneChem (Shanghai, China). Stable cell lines were selected with 0.5 μg/ml puromycin (PTRH1 oe cells) for 2 days.
+ Open protocol
+ Expand
6

Regulatory Mechanisms of LINC00265 and STAT3

Check if the same lab product or an alternative is used in the 5 most similar protocols
LINC00265 siRNA and negative control, miR-4500 mimics and inhibitor, STAT3 siRNA and negative control were purchased from Ribobio (Guangzhou, China). LINC00265 or STAT3 wild-type (WT) and mutant-type (MT) plasmids and corresponding blank plasmids were prepared in our laboratory. Molt-3 and SUP-B15 cells were seeded in 12-wells plates and cultured for 12 h before transfection. For transient transfection, LINC00265 siRNA, miR-4500 mimics, STAT3 siRNA, and recombinant plasmid were transfected using Lipofectamine 2000 (Invitrogen). Samples were collected after 24 h for the quantification of target gene expression.
+ Open protocol
+ Expand
7

miR-29a and STAT3 Regulation in EC Cells

Check if the same lab product or an alternative is used in the 5 most similar protocols
Human EC cell line HHUC was purchased from the Cell Resource Center of Shanghai Institute of Biosciences, Chinese Academy of Sciences. EC cells were stored in DMEM with 10% fetal bovine serum at 37 ℃ and in 5% CO 2 . miR-29a mimics or inhibitors, STAT3 plasmids (overexpressed STAT3 and STAT3-OE) or shRNA (knockdown of STAT3 and STAT3-KD) were transfected into 6-well plates. Liposome 2000 (Thermo Fisher Science) with untreated HHUC were used as the negative control (NC). miR-29a mimics, miR-29a inhibitors, STAT3 plasmids (pcDNA3.1-STAT3) and STAT3-siRNA were all purchased from Ribobio (RiboBio Co.Ltd., China).
+ Open protocol
+ Expand
8

siRNA-mediated STAT3 Knockdown

Check if the same lab product or an alternative is used in the 5 most similar protocols
A negative control small interfering RNA (siRNA) and siRNA-stat3 were obtained from RIBo. Transfection was performed according to the manufacturer’s protocol. The target sequence used in this study was as follows: 5′-GCACAATCTACGAAGAATCAA-3′.
+ Open protocol
+ Expand
9

Modulation of Hepatocyte Proliferation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Treatments of this part were conducted as our previously described [61 (link)]. Briefly, BRL-3A cells were obtained from cell bank of the School of Basic Medicine of Peking Union Medical College (Beijing, China). The cells had been kept in a high glucose DMEM complete medium, supplemented with 10% fetal bovine serum (FBS), 1% penicillin and 1%streptomycin in a concentration of 5% CO2 incubator at 37 °C. miR-125a mimics (Ribobio, Guangzhou, China), miR-125a inhibitor (Ribobio, China), or their negative controls handled BRL-3A for 48 h, respectively. To further investigate the role of STAT3 in hepatocyte proliferation, cells were transfected with siRNA-STAT3 (siRNA1, 2, 3, Ribobio, China) or negative control for 48 h, respectively.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!